Association of BCG Vaccination in Childhood with Subsequent Cancer Diagnoses: A 60-Year Follow-up of a Clinical Trial

Keyphrases

• Subsequent Cancer 100%
• Clinical Trials 100%
• Cancer Diagnosis 100%
• BCG Vaccine 100%
• 60-year Follow-up 100%
• Placebo Groups 36%
• Placebo 27%
• Lung Cancer 18%
• Hazard Ratio 18%
• Leukemia 18%
• Lymphoma 18%
• Tuberculosis Infection 18%
• Alaska Native 18%
• Risk Factors 9%
• Low Risk 9%
• Alcohol 9%
• Lung Cancer Risk 9%
• Mycobacterium Tuberculosis (M. tb) 9%
• Retrospective Review 9%
• Statistical Analysis 9%
• Excess Mortality 9%
• Health Implications 9%
• Cancer Development 9%
• Vaccination 9%
• Demographic Information 9%
• Total Mortality 9%
• Schoolchildren 9%
• Cancer Incidence 9%
• Overall Rate 9%
• Group by 9%
• US States 9%
• Vaccine Trial 9%
• Intradermal Injection 9%
• Tuberculosis Vaccine 9%
• Health Factors 9%
• Native Population 9%
• School Districts 9%
• Vaccinated Individuals 9%

Medicine and Dentistry

• Clinical Trial 100%
• Cancer Diagnosis 100%
• BCG Vaccination 100%
• BCG Vaccine 100%
• Placebo 87%
• Mycobacterium Bovis BCG 50%
• Lung Cancer 37%
• Tuberculosis 37%
• Malignant Neoplasm 25%
• Hazard Ratio 25%
• Leukemia 25%
• Mortality Rate 12%
• Infancy 12%
• Intradermal Drug Administration 12%
• Isoniazid 12%
• Table Salt 12%
• Cost Efficiency 12%

Nursing and Health Professions

• BCG Vaccination 100%
• Cancer Diagnosis 100%
• BCG Vaccine 100%
• Clinical Trial 100%
• Placebo 87%
• Lung Cancer 37%
• Tuberculosis 37%
• Malignant Neoplasm 25%
• Hazard Ratio 25%
• Leukemia 25%
• Mortality Rate 12%
• Isoniazid 12%
• Intradermal Drug Administration 12%
• Table Salt 12%